Johnson Financial Group Inc. raised its stake in Danaher Corporation (NYSE:DHR) by 70.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,929 shares of the conglomerate’s stock after acquiring an additional 1,627 shares during the quarter. Johnson Financial Group Inc.’s holdings in Danaher were worth $337,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. GQG Partners LLC acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $101,000. Proficio Capital Partners LLC grew its position in shares of Danaher by 92.3% during the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after buying an additional 598 shares during the period. Monetary Management Group Inc. grew its position in shares of Danaher by 10.7% during the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after buying an additional 150 shares during the period. Acrospire Investment Management LLC grew its position in shares of Danaher by 185.5% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after buying an additional 1,100 shares during the period. Finally, Motco grew its position in shares of Danaher by 8.8% during the 2nd quarter. Motco now owns 2,011 shares of the conglomerate’s stock worth $170,000 after buying an additional 163 shares during the period. Hedge funds and other institutional investors own 76.32% of the company’s stock.
Danaher Corporation (DHR) opened at $93.82 on Monday. The stock has a market cap of $65,261.68, a P/E ratio of 24.12, a P/E/G ratio of 2.23 and a beta of 1.02. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. Danaher Corporation has a 1-year low of $76.27 and a 1-year high of $94.82.
In other Danaher news, SVP Daniel Raskas sold 37,870 shares of Danaher stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total value of $3,534,407.10. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Robert S. Lutz sold 11,189 shares of Danaher stock in a transaction that occurred on Monday, October 23rd. The shares were sold at an average price of $91.66, for a total transaction of $1,025,583.74. Following the completion of the transaction, the chief accounting officer now directly owns 18,314 shares in the company, valued at approximately $1,678,661.24. The disclosure for this sale can be found here. In the last ninety days, insiders sold 273,810 shares of company stock worth $25,218,813. Insiders own 12.20% of the company’s stock.
Several equities research analysts have recently commented on the stock. Cowen reiterated a “buy” rating and set a $90.00 price target on shares of Danaher in a research report on Wednesday, October 4th. Morgan Stanley reiterated an “overweight” rating and set a $95.00 price target (up previously from $86.00) on shares of Danaher in a research report on Friday, October 6th. Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $97.00 price target for the company in a research report on Thursday, October 5th. Robert W. Baird boosted their price objective on shares of Danaher from $87.00 to $97.00 and gave the company an “outperform” rating in a report on Friday, October 20th. Finally, J P Morgan Chase & Co restated an “overweight” rating and set a $95.00 price objective on shares of Danaher in a report on Friday, September 8th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $93.31.
ILLEGAL ACTIVITY NOTICE: “Johnson Financial Group Inc. Boosts Holdings in Danaher Corporation (DHR)” was published by Week Herald and is the property of of Week Herald. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at https://weekherald.com/2017/12/04/johnson-financial-group-inc-boosts-holdings-in-danaher-corporation-dhr.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.